Labetalol Nardia 5 mg/ml (100 mg per 20 ml)

Labetalol Nardia 5 mg/ml (100 mg per 20 ml) is a medicine authorised by Swissmedic under authorisation number 70383. The authorisation holder is Nardia Pharmaceuticals SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 12 May 2026 and the authorisation is limited until 11 May 2031. ATC code C07AG01 places the medicine in the group Beta blocking agents.

  • Dispensing category B
  • Authorisation number 70383
  • ATC C07AG01
  • Synthetic medicines
Authorisation data
Authorisation number70383
NameLabetalol Nardia 5 mg/ml (100 mg per 20 ml)
Full nameLabetalol Nardia 5 mg/ml (100 mg per 20 ml), Injektions-/Infusionslösung
Authorisation holderNardia Pharmaceuticals SA
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC07AG01
First authorisation12 May 2026
Authorisation validity11 May 2031
Strengths
No.NameDispensing categoryAuthorisation date
1Labetalol Nardia 5 mg/ml (100 mg per 20 ml), Injektions-/InfusionslösungB12 May 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
15Ampulle(n)C07AG0102.03.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Labetalol Nardia 5 mg/ml (100 mg per 20 ml) authorised in Switzerland?

Yes. Labetalol Nardia 5 mg/ml (100 mg per 20 ml) is authorised by Swissmedic under authorisation number 70383, data as of 01 September 2026. The authorisation is limited until 11 May 2031.

Which dispensing category does Labetalol Nardia 5 mg/ml (100 mg per 20 ml) have?

Labetalol Nardia 5 mg/ml (100 mg per 20 ml) is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Labetalol Nardia 5 mg/ml (100 mg per 20 ml)?

The authorisation holder is Nardia Pharmaceuticals SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com